High Sensitivity and Specificity of the Xenium Platform from 10x Genomics Outperforms NanoString’s CosMx and Vizgen’s Merscope in Benchmarking Preprint

Xenium In Situ demonstrates higher transcript counts per gene in new comparison study of three spatial imaging platforms PLEASANTON, Calif., Dec. 13, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that a new…

Click here to view original post